Topics

Syros Reports First Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

07:30 EDT 1 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Successfully Completed $70 Million Financing On Track for Multiple Data Readouts for Clinical-Stage Programs in 2019 and 2020 Management to Host Conference Call at 8:30 a.m. ET Today Syros Pharmaceut...

Other Sources for this Article

Media Contact:
Naomi Aoki
Syros Pharmaceuticals
617-283-4298
naoki@syros.com

Investor Contact:
Hannah Deresiewicz
Stern Investor Relations, Inc.
212-362-1200
hannah.deresiewicz@sternir.com

NEXT ARTICLE

More From BioPortfolio on "Syros Reports First Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...